Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Shares Down 6 Percent on Q2 Loss

NEW YORK (GenomeWeb News) - Shares in Stratagene were down approximately 6 percent, or $.43, at $6.41 in mid-afternoon trading today after the company said that litigation-related charges swung second-quarter earnings to a loss.
 
As GenomeWeb News reported this morning, Stratagene said total revenues were down 6 percent to $23.4 million due to poor sales of its gene-discovery and cloning systems products.
 
The company’s net loss of $3.7 million reflects the litigation charges from the patent case involving Invitrogen's patents.
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.